SCHEMBL8098968

SCHEMBL8098968

CC(CNCC(C)c1ccc2ccccc2c1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 11/20 0.51
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
TSHR P16473 1/20 0.51
KMT2A Q03164 1/20 0.51
HIF1A Q16665 1/20 0.51
SLC6A2 P23975 13/20 0.51
SLC6A4 P31645 13/20 0.51
SLC6A3 Q01959 13/20 0.51
KCNH2 Q12809 12/20 0.51
CYP3A4 P08684 8/20 0.51
TAAR1 Q96RJ0 1/20 0.50
UGT2B7 P16662 1/20 0.50
AOC3 Q16853 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23330351 0.90 UGT2B7 (0.55) CYP2D6MEN1CYP1A2TSHRKMT2A
SCHEMBL11046082 0.83 TAAR1 (0.68) MEN1KMT2ATAAR1AOC3
SCHEMBL9668424 0.82 SLC6A2 (0.59) CYP2D6MEN1CYP1A2TSHRKMT2A
SCHEMBL8093079 0.80 MEN1 (0.59) MEN1KMT2ATAAR1
SCHEMBL17308024 0.77 TAAR1 (0.61) MEN1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL8091056 0.77 SIGMAR1 (0.58) MEN1CYP1A2KMT2AKCNH2
SCHEMBL8098965 0.76 SLC6A2 (0.46) CYP2D6MEN1CYP1A2TSHRKMT2A
SCHEMBL5401290 0.76 UGT2B7 (0.59) CYP2D6MEN1CYP1A2TSHRKMT2A
Hydrochloric Acid SCHEMBL15573475 0.76 TAAR1 (0.64) MEN1KMT2ACYP3A4TAAR1AOC3
SCHEMBL16684715 0.76 UGT2B7 (0.59) CYP2D6MEN1CYP1A2TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP claimed
EP-0507863-A4 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF 1993-07-07 EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO claimed
EP-0507863-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1992-10-14 EP claimed
WO-1991009594-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1991-07-11 WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 WO disclosed
WO-1991009594-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1991-07-11 WO disclosed